HTRS Hosts Webinar: Novel Therapies In VWD And Rare Bleeding Disorders
Hemostasis & Thrombosis Research Society (HTRS) posted on LinkedIn:
”Join HTRS for our upcoming educational webinar: “Novel Therapies in VWD and Rare Bleeding Disorders” on Tuesday, October 21 at 3:00PM EST.
Discover the latest advances in treatment and research for von Willebrand disease (VWD) and rare bleeding disorders with two renowned experts:
Dr. Debbie Jiang – Adult classical hematologist at Massachusetts General Hospital and the Boston Bleeding Disorders Center. A recipient of the HTRS/Novo Nordisk Clinical Scholar Award, Dr. Jiang is dedicated to advancing care and research for bleeding and clotting disorders.
Dr. Stacy Croteau – Pediatric hematologist and clinical researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. As Medical Director of the Boston Bleeding Disorders Center and National Chair of the ATHN/NHPCC Transition Working Group, Dr. Croteau leads efforts to improve outcomes and transitions of care for individuals with bleeding disorders.
Don’t miss this opportunity to hear directly from leaders shaping the future of bleeding disorder care. Register now to secure your spot.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 18:24Celebrating Emna Gouider’s Renewed Leadership at WFH Congress 2026 – WFH
-
Jun 15, 2026, 18:14Anastasia Conti: Connecting Celebrating and Advancing Hematology at EHA 2026
-
Jun 15, 2026, 18:01Eric Mwenda: Honoring Blood Donors and Partnerships in Tanzania
-
Jun 15, 2026, 17:37Vincent Elsey: The Ethereal Anatomy of a Broken Vessel
-
Jun 15, 2026, 17:20Megan Adediran: Small Act, Massive Impact – Celebrating Blood Donor Day
-
Jun 15, 2026, 16:52Alejandro González Veliz: A Modern Approach to Anticoagulant Management
-
Jun 15, 2026, 16:20New Therapeutic Strategies Targeting Iron Metabolism
-
Jun 15, 2026, 15:43Antonio Paul: Donor Safety Is More Than a Sterile Needle
-
Jun 15, 2026, 15:36Alejandro González Veliz: A Coronary Calcium Score of Zero Doesn’t Always Mean Zero Risk